查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2065239

個人化營養與基因體學市場預測至2034年－按產品類型、技術、成分、給藥方式、劑型、最終用戶及地區分類的全球分析

Personalized Nutrition and Genomics Market Forecasts to 2034 - Global Analysis By Product Type, Technology, Component, Delivery Mode, Dosage Form, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球個人化營養和基因組學市場預計將在 2026 年達到 94 億美元，到 2034 年達到 321 億美元，在預測期內以 16.5% 的複合年成長率成長。

個人化營養和基因組學市場涵蓋了一個快速擴張的產品和服務生態系統，該系統利用基因分析、微生物組分析、代謝體學和人工智慧數據解讀，為每個人量身定做個性化的膳食建議、營養補充劑配方和健康干預措施，以滿足其獨特的生物學特徵。透過整合遺傳傾向、表觀遺傳標記、腸道菌群組成以及來自穿戴式裝置的即時生物標記數據，這些平台正超越群體層面的飲食指南，發展成為能夠最佳化健康結果的精準營養策略。

消費者對預防醫學和個人化健康管理的興趣日益濃厚

消費者對健康的態度發生了根本性的轉變——從被動地治療疾病轉向積極地最佳化健康——這顯著提升了對個性化營養解決方案的需求，這類方案能夠基於個體生物數據提供切實可行的膳食指導。健康素養的提升、消費者基因檢測的普及以及健康追蹤穿戴式裝置的廣泛應用，使得消費者更加關注自身的健康數據，也更願意參與個人化營養計畫。包括肥胖、第二型糖尿病和心血管疾病風險在內的慢性疾病負擔，正促使消費者和醫療保健提供者轉向精準的膳食干預，而精準的膳食干預已被證明在管理代謝健康指標方面比一般的營養指導更為有效。

缺乏臨床檢驗，消費者對基因營養的說法持懷疑態度。

將特定基因突變與精確營養需求聯繫起來的科學證據尚不完整，並且是許多營養基因組學組織爭論的焦點，這給標榜療效的個人化營養公司帶來了信譽挑戰。監管消費者基因健康聲明的框架正受到監管機構的日益嚴格審查，這些機構關注的是未經證實的醫療聲明。消費者對資料隱私，尤其是基因資訊保密性的疑慮，是推廣應用的一大障礙，需要透明的資料管治和強而有力的安全措施來克服。此外，全面的個人化營養方案價格高昂，進一步限制了其市場滲透，使其主要面向富裕消費者。

整合連續生物標記監測和基於訂閱的營養平台

持續血糖監測、微生物組檢測和穿戴式生理感測器，結合人工智慧驅動的營養推薦引擎，打造出強大的即時個人化功能，能夠根據個人全天不斷變化的生物標記模式動態調整飲食指導。這種基於訂閱的個人化營養平台，融合了檢測、數位指導和客製化營養補充品配送，正在建立一個高收益、高客戶終身價值的商業模式。製藥和營養保健品公司正積極投資個人化營養領域的合作，以確保獲取其獨特的消費者健康數據資產，並透過精準的配方策略，使其通用營養補充品產品脫穎而出。

基因組資料的監理格局及安全風險

個人化營養領域涉及多個監管領域，包括食品、膳食補充劑、醫療設備和基因檢測服務。每個領域都有其獨特且有時相互矛盾的監管要求，各國之間的差異也很大。應對這種複雜的局面會增加合規成本和產品上市時間，尤其對於那些宣稱具有健康益處並受到嚴格監管審查的公司而言更是如此。基因資料的安全性是一個特別脆弱的環節，消費者基因組資料庫的大規模資料外洩事件就充分證明了這一點，這事件損害了公眾對消費者基因檢測服務的信任。未來若再發生大規模的基因組資料安全事件，可能會顯著降低人們參與個人化營養計畫的意願。

新型冠狀病毒（COVID-19）的影響

新冠疫情顯著加速了消費者對個人化營養和基因組學的接受度，提高了人們對免疫功能、代謝健康以及疾病易感性和康復能力個體差異的認知。消費者尋求個人化指導，以最佳化自身營養狀況，從而在感染新冠病毒期間及之後維持和增強免疫力。疫情引發的居家健康檢查激增，使得消費者診斷服務更加普及，並降低了人們對參與居家健康計畫的抵觸情緒。疫情結束後，消費者對最佳化健康的關注依然持續，他們對將個人化營養平台作為綜合預防性健康策略一部分的興趣仍然很高。

預計在預測期內，人工智慧驅動的個人化餐飲平台細分市場將成為最大的細分市場。

預計在預測期內，人工智慧驅動的個人化飲食平台將佔據最大的市場佔有率。這主要歸功於消費者對數位營養指導應用的廣泛接受。這些應用程式整合了多種健康數據流，提供個人化的飲食計劃、營養補充指導和行為習慣建議。這些平台不僅能夠獲得可觀的定期訂閱收入，還能透過不斷學習用戶數據來持續提高推薦的準確性。與穿戴式裝置製造商和外送服務商的合作，正在拓展平台在整個消費者健康生態系統中的效用和商業性影響力。

預計在預測期內，「基於微生物組的營養解決方案」細分市場將呈現最高的複合年成長率。

在預測期內，基於微生物組的營養解決方案領域預計將呈現最高的成長率，這主要得益於人們對腸道菌群對代謝健康、免疫功能、情緒和慢性疾病風險影響的科學認知迅速擴展。這導致消費者對微生物組分析以及針對性益生菌和益生元干預方案的需求顯著成長。微生物組定序技術的成本降低以及對先進生物資訊分析的投資正在加速將研究成果轉化為可操作的消費者營養建議。將微生物組檢測與個人化飲食改善指導相結合的領先平台正吸引著全球範圍內的大量風險投資和消費者關注。

市佔率最大的地區

在預測期內，北美地區預計將佔據最大的市場佔有率，這主要得益於消費者較高的健康意識、較高的消費者基因檢測普及率以及由創業投資推動精準營養技術發展的蓬勃發展的初創企業生態系統。美國正引領全球市場的發展，這得益於美國食品藥物管理局（FDA）現有框架內對營養基因組學標籤的有利法規環境，以及消費者對高階個人化健康產品的投資意願。總部位於北美的領導企業正在推動全球商業化策略和平台創新。

複合年成長率最高的地區

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中產階級對高階健康最佳化產品需求的快速成長、中國、日本和韓國消費者基因檢測基礎設施的不斷完善，以及該地區根深蒂固的重視飲食療法以維持健康的文化傳統。亞太地區多個國家正在實施政府支持的精準醫療和營養基因組學研究項目，這些項目正在建立科學信譽和融入臨床實踐的管道。智慧型手機的日益普及正在加速該地區眾多注重健康的消費者使用數位營養平台。

免費客製化服務

所有購買此報告的客戶均可選擇以下免費自訂選項之一。

  • 企業概況
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 透過產品系列、地域覆蓋和策略聯盟對標領先企業。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 成長機會和重點投資領域
  • 工業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球個人化營養與基因體學市場：依產品類型分類

  • 基於DNA的營養計劃
  • 基於微生物組的營養解決方案
  • 個人化補充品
  • 人工智慧驅動的個人化膳食平台
  • 基於生物標記的營養計劃
  • 個人化食材自煮包
  • 行動營養與健康應用程式

第6章：全球個人化營養與基因體學市場：依技術分類

  • 營養基因體學
  • 營養遺傳學
  • 表觀遺傳學
  • 代謝體學
  • 蛋白質體學
  • 微生物組學
  • 人工智慧和機器學習
  • 穿戴式感測器技術

第7章 全球個人化營養與基因體學市場：依組成部分分類

  • 產品
    • 檢測套組
    • 試劑和耗材
    • 軟體平台
    • 穿戴式裝置
  • 服務
    • 基因檢測服務
    • 膳食諮詢服務
    • 訂閱式營養服務
    • 數據分析服務

第8章：全球個人化營養和基因組學市場：按交付方式分類

  • 直接面對消費者銷售（DTC）
  • 專家主導的項目
  • 數位/線上平台
  • 零售型個人化營養

第9章：全球個人化營養與基因組學市場：按劑型分類

  • 片劑和膠囊
  • 粉末
  • 液體配方
  • 軟糖/咀嚼片
  • 功能性食品和飲料

第10章：全球個人化營養與基因組學市場：依最終用戶分類

  • 健身愛好者
  • 運動員和運動專家
  • 一般消費者
  • 老年人
  • 兒童人口
  • 慢性疾病患者
  • 醫療保健和健康企業

第11章 全球個人化營養與基因組學市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 其他
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲地區

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章：產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟、合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Nestle Health Science
  • GenoPalate
  • Persona Nutrition
  • Abbott Laboratories
  • DNAfit
  • Nutrigenomix
  • Viome Life Sciences
  • Metagenics, Inc.
  • BASF SE
  • Danone SA
  • InsideTracker
  • Herbalife Nutrition
  • dsm-firmenich
  • 23andMe
  • Amway Corporation
Product Code: SMRC36757

According to Stratistics MRC, the Global Personalized Nutrition and Genomics Market is accounted for $9.4 billion in 2026 and is expected to reach $32.1 billion by 2034, growing at a CAGR of 16.5% during the forecast period. The Personalized Nutrition and Genomics market encompasses a rapidly expanding ecosystem of products and services that leverage genetic analysis, microbiome profiling, metabolomics, and AI-powered data interpretation to deliver individualized dietary recommendations, supplement formulations, and wellness interventions tailored to each person's unique biological profile. By integrating genetic predispositions, epigenetic markers, gut microbiota composition, and real-time biomarker data from wearable devices, these platforms move beyond population-level dietary guidelines toward precision nutrition strategies that optimize health outcomes.

Market Dynamics:

Driver:

Growing consumer interest in preventive health and personalized wellness

A fundamental shift in consumer health philosophy from reactive disease treatment toward proactive wellness optimization is generating substantial demand for personalized nutrition solutions that provide actionable dietary guidance grounded in individual biological data. Rising health literacy, direct-to-consumer genetic testing adoption, and the widespread use of health tracking wearables are equipping consumers with personal health data and motivating engagement with personalized nutrition programs. Chronic disease burden including obesity, type 2 diabetes, and cardiovascular risk is driving both consumers and healthcare providers toward precision dietary interventions demonstrated to outperform generic nutritional guidance in managing metabolic health markers.

Restraint:

Limited clinical validation and consumer skepticism regarding genetic nutrition claims

The scientific evidence base connecting specific genetic variants to precise nutritional requirements remains incomplete and contested across many nutrigenomics associations, creating credibility challenges for personalized nutrition companies making efficacy claims. Regulatory frameworks governing direct-to-consumer genetic health claims are increasingly scrutinized by agencies concerned about unsubstantiated medical assertions. Consumer skepticism regarding data privacy particularly sensitivity around genetic information creates adoption barriers that require transparent data governance and robust security commitments to overcome. The premium pricing of comprehensive personalized nutrition programs further restricts addressable market penetration to financially advantaged consumer segments.

Opportunity:

Integration of continuous biomarker monitoring and subscription nutrition platforms

The convergence of continuous glucose monitors, microbiome testing, and wearable physiological sensors with AI-driven nutrition recommendation engines is creating powerful real-time personalization capabilities that adapt dietary guidance dynamically to an individual's evolving biomarker patterns throughout the day. Subscription-based personalized nutrition platforms that combine testing, digital coaching, and customized supplement delivery are building recurring revenue models with strong customer lifetime value economics. Pharmaceutical and nutraceutical companies are investing in personalized nutrition partnerships to access proprietary consumer health data assets and differentiate commodity supplement products through precision formulation strategies.

Threat:

Fragmented regulatory landscape and genomic data security risks

The personalized nutrition sector operates across multiple regulatory domains food, dietary supplements, medical devices, and genetic testing services each with distinct and sometimes conflicting regulatory requirements that vary substantially across national markets. Navigating this complexity increases compliance costs and time-to-market, particularly for companies seeking to make health improvement claims that attract regulatory scrutiny. Genetic data security represents a particularly sensitive vulnerability, as demonstrated by high-profile breaches of consumer genomics databases that have eroded public confidence in direct-to-consumer genetic testing services. Any further major genomic data security incidents could significantly dampen consumer willingness to participate in personalized nutrition programs.

Covid-19 Impact:

The COVID-19 pandemic significantly accelerated consumer adoption of personalized nutrition and genomics by heightening awareness of immune function, metabolic health, and the individualized nature of disease vulnerability and recovery. Consumers sought personalized guidance for optimizing their nutritional status to support immune resilience during and after COVID-19 infection. The pandemic-driven surge in at-home health testing normalized direct-to-consumer diagnostic engagement and expanded comfort with home-based wellness program participation. Post-pandemic, sustained consumer engagement with health optimization has maintained elevated interest in personalized nutrition platforms as part of integrated preventive wellness strategies.

The AI-Driven Personalized Diet Platforms segment is expected to be the largest during the forecast period

The AI-driven personalized diet platforms segment is expected to account for the largest market share during the forecast period, driven by widespread consumer adoption of digital nutrition coaching applications that integrate multiple health data streams to deliver individualized meal planning, supplementation guidance, and behavioral habit recommendations. These platforms generate scalable recurring subscription revenues while continuously refining recommendation accuracy through expanding user data training. Partnerships with wearable device manufacturers and food delivery services extend platform utility and commercial reach across consumer health ecosystems.

The Microbiome-Based Nutrition Solutions segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Microbiome-Based Nutrition Solutions segment is predicted to witness the highest growth rate, driven by rapidly expanding scientific understanding of gut microbiota's influence on metabolic health, immune function, mood, and chronic disease risk, creating compelling consumer demand for microbiome profiling and targeted probiotic or prebiotic intervention programs. Investment in microbiome sequencing technology cost reduction and bioinformatic analysis sophistication is accelerating translation from research findings to actionable consumer nutrition recommendations. Leading platforms combining microbiome testing with personalized dietary modification guidance are attracting substantial venture investment and consumer interest globally.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by high consumer health consciousness, strong direct-to-consumer genetic testing adoption, and an active venture-backed startup ecosystem advancing precision nutrition technology. The United States leads global market development, supported by a favorable regulatory environment for nutrigenomic claims under current FDA dietary supplement frameworks and robust consumer willingness to invest in premium personalized health products. Leading companies headquartered in North America drive global commercialization strategies and platform innovation.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, propelled by rapidly growing middle-class consumer demand for premium health optimization products, expanding consumer genetics infrastructure in China, Japan, and South Korea, and strong cultural traditions emphasizing dietary approaches to health maintenance. Government-supported precision medicine and nutrigenomics research programs in several Asia Pacific nations are building scientific credibility and clinical integration pathways. Rising smartphone adoption enables digital nutrition platform engagement across the region's large and health-conscious consumer population.

Key players in the market

Some of the key players in Personalized Nutrition and Genomics Market include Nestle Health Science, GenoPalate, Persona Nutrition, Abbott Laboratories, DNAfit, Nutrigenomix, Viome Life Sciences, Metagenics, Inc., BASF SE, Danone S.A., InsideTracker, Herbalife Nutrition, dsm-firmenich, 23andMe, and Amway Corporation.

Key Developments:

In March 2026, Viome Life Sciences announced a significant expansion of its full-body intelligence platform, integrating transcriptomic and proteomic biomarker analysis alongside its established microbiome profiling capabilities to deliver a more comprehensive biological health assessment informing its AI-powered personalized nutrition and supplement recommendations.

In January 2026, Nestle Health Science launched a new precision nutrition initiative targeting metabolic health management, combining genetic predisposition screening with continuous glucose monitoring data integration and AI-powered dietary coaching through a dedicated digital health application supporting individualized cardiometabolic risk reduction programs.

Product Types Covered:

  • DNA-Based Nutrition Plans
  • Microbiome-Based Nutrition Solutions
  • Personalized Supplements
  • AI-Driven Personalized Diet Platforms
  • Biomarker-Based Nutrition Programs
  • Personalized Meal Kits
  • Mobile Nutrition & Wellness Applications

Technologies Covered:

  • Nutrigenomics
  • Nutrigenetics
  • Epigenetics
  • Metabolomics
  • Proteomics
  • Microbiomics
  • Artificial Intelligence & Machine Learning
  • Wearable & Sensor Technologies

Components Covered:

  • Products
  • Services

Delivery Modes Covered:

  • Direct-to-Consumer (DTC)
  • Practitioner-Based Programs
  • Digital/Online Platforms
  • Retail-Based Personalized Nutrition

Dosage Forms Covered:

  • Tablets & Capsules
  • Powders
  • Liquids
  • Gummies & Chewables
  • Functional Foods & Beverages

End Users Covered:

  • Fitness Enthusiasts
  • Athletes & Sports Professionals
  • General Consumers
  • Geriatric Population
  • Pediatric Population
  • Patients with Chronic Diseases
  • Healthcare & Wellness Providers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Personalized Nutrition and Genomics Market, By Product Type

  • 5.1 DNA-Based Nutrition Plans
  • 5.2 Microbiome-Based Nutrition Solutions
  • 5.3 Personalized Supplements
  • 5.4 AI-Driven Personalized Diet Platforms
  • 5.5 Biomarker-Based Nutrition Programs
  • 5.6 Personalized Meal Kits
  • 5.7 Mobile Nutrition & Wellness Applications

6 Global Personalized Nutrition and Genomics Market, By Technology

  • 6.1 Nutrigenomics
  • 6.2 Nutrigenetics
  • 6.3 Epigenetics
  • 6.4 Metabolomics
  • 6.5 Proteomics
  • 6.6 Microbiomics
  • 6.7 Artificial Intelligence & Machine Learning
  • 6.8 Wearable & Sensor Technologies

7 Global Personalized Nutrition and Genomics Market, By Component

  • 7.1 Products
    • 7.1.1 Test Kits
    • 7.1.2 Reagents & Consumables
    • 7.1.3 Software Platforms
    • 7.1.4 Wearable Devices
  • 7.2 Services
    • 7.2.1 Genetic Testing Services
    • 7.2.2 Dietary Consultation Services
    • 7.2.3 Subscription-Based Nutrition Services
    • 7.2.4 Data Analytics Services

8 Global Personalized Nutrition and Genomics Market, By Delivery Mode

  • 8.1 Direct-to-Consumer (DTC)
  • 8.2 Practitioner-Based Programs
  • 8.3 Digital/Online Platforms
  • 8.4 Retail-Based Personalized Nutrition

9 Global Personalized Nutrition and Genomics Market, By Dosage Form

  • 9.1 Tablets & Capsules
  • 9.2 Powders
  • 9.3 Liquids
  • 9.4 Gummies & Chewables
  • 9.5 Functional Foods & Beverages

10 Global Personalized Nutrition and Genomics Market, By End User

  • 10.1 Fitness Enthusiasts
  • 10.2 Athletes & Sports Professionals
  • 10.3 General Consumers
  • 10.4 Geriatric Population
  • 10.5 Pediatric Population
  • 10.6 Patients with Chronic Diseases
  • 10.7 Healthcare & Wellness Providers

11 Global Personalized Nutrition and Genomics Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Nestle Health Science
  • 14.2 GenoPalate
  • 14.3 Persona Nutrition
  • 14.4 Abbott Laboratories
  • 14.5 DNAfit
  • 14.6 Nutrigenomix
  • 14.7 Viome Life Sciences
  • 14.8 Metagenics, Inc.
  • 14.9 BASF SE
  • 14.10 Danone S.A.
  • 14.11 InsideTracker
  • 14.12 Herbalife Nutrition
  • 14.13 dsm-firmenich
  • 14.14 23andMe
  • 14.15 Amway Corporation

List of Tables

  • Table 1 Global Personalized Nutrition and Genomics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Personalized Nutrition and Genomics Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Personalized Nutrition and Genomics Market Outlook, By DNA-Based Nutrition Plans (2023-2034) ($MN)
  • Table 4 Global Personalized Nutrition and Genomics Market Outlook, By Microbiome-Based Nutrition Solutions (2023-2034) ($MN)
  • Table 5 Global Personalized Nutrition and Genomics Market Outlook, By Personalized Supplements (2023-2034) ($MN)
  • Table 6 Global Personalized Nutrition and Genomics Market Outlook, By AI-Driven Personalized Diet Platforms (2023-2034) ($MN)
  • Table 7 Global Personalized Nutrition and Genomics Market Outlook, By Biomarker-Based Nutrition Programs (2023-2034) ($MN)
  • Table 8 Global Personalized Nutrition and Genomics Market Outlook, By Personalized Meal Kits (2023-2034) ($MN)
  • Table 9 Global Personalized Nutrition and Genomics Market Outlook, By Mobile Nutrition & Wellness Applications (2023-2034) ($MN)
  • Table 10 Global Personalized Nutrition and Genomics Market Outlook, By Technology (2023-2034) ($MN)
  • Table 11 Global Personalized Nutrition and Genomics Market Outlook, By Nutrigenomics (2023-2034) ($MN)
  • Table 12 Global Personalized Nutrition and Genomics Market Outlook, By Nutrigenetics (2023-2034) ($MN)
  • Table 13 Global Personalized Nutrition and Genomics Market Outlook, By Epigenetics (2023-2034) ($MN)
  • Table 14 Global Personalized Nutrition and Genomics Market Outlook, By Metabolomics (2023-2034) ($MN)
  • Table 15 Global Personalized Nutrition and Genomics Market Outlook, By Proteomics (2023-2034) ($MN)
  • Table 16 Global Personalized Nutrition and Genomics Market Outlook, By Microbiomics (2023-2034) ($MN)
  • Table 17 Global Personalized Nutrition and Genomics Market Outlook, By Artificial Intelligence & Machine Learning (2023-2034) ($MN)
  • Table 18 Global Personalized Nutrition and Genomics Market Outlook, By Wearable & Sensor Technologies (2023-2034) ($MN)
  • Table 19 Global Personalized Nutrition and Genomics Market Outlook, By Component (2023-2034) ($MN)
  • Table 20 Global Personalized Nutrition and Genomics Market Outlook, By Products (2023-2034) ($MN)
  • Table 21 Global Personalized Nutrition and Genomics Market Outlook, By Test Kits (2023-2034) ($MN)
  • Table 22 Global Personalized Nutrition and Genomics Market Outlook, By Reagents & Consumables (2023-2034) ($MN)
  • Table 23 Global Personalized Nutrition and Genomics Market Outlook, By Software Platforms (2023-2034) ($MN)
  • Table 24 Global Personalized Nutrition and Genomics Market Outlook, By Wearable Devices (2023-2034) ($MN)
  • Table 25 Global Personalized Nutrition and Genomics Market Outlook, By Services (2023-2034) ($MN)
  • Table 26 Global Personalized Nutrition and Genomics Market Outlook, By Genetic Testing Services (2023-2034) ($MN)
  • Table 27 Global Personalized Nutrition and Genomics Market Outlook, By Dietary Consultation Services (2023-2034) ($MN)
  • Table 28 Global Personalized Nutrition and Genomics Market Outlook, By Subscription-Based Nutrition Services (2023-2034) ($MN)
  • Table 29 Global Personalized Nutrition and Genomics Market Outlook, By Data Analytics Services (2023-2034) ($MN)
  • Table 30 Global Personalized Nutrition and Genomics Market Outlook, By Delivery Mode (2023-2034) ($MN)
  • Table 31 Global Personalized Nutrition and Genomics Market Outlook, By Direct-to-Consumer (DTC) (2023-2034) ($MN)
  • Table 32 Global Personalized Nutrition and Genomics Market Outlook, By Practitioner-Based Programs (2023-2034) ($MN)
  • Table 33 Global Personalized Nutrition and Genomics Market Outlook, By Digital/Online Platforms (2023-2034) ($MN)
  • Table 34 Global Personalized Nutrition and Genomics Market Outlook, By Retail-Based Personalized Nutrition (2023-2034) ($MN)
  • Table 35 Global Personalized Nutrition and Genomics Market Outlook, By Dosage Form (2023-2034) ($MN)
  • Table 36 Global Personalized Nutrition and Genomics Market Outlook, By Tablets & Capsules (2023-2034) ($MN)
  • Table 37 Global Personalized Nutrition and Genomics Market Outlook, By Powders (2023-2034) ($MN)
  • Table 38 Global Personalized Nutrition and Genomics Market Outlook, By Liquids (2023-2034) ($MN)
  • Table 39 Global Personalized Nutrition and Genomics Market Outlook, By Gummies & Chewables (2023-2034) ($MN)
  • Table 40 Global Personalized Nutrition and Genomics Market Outlook, By Functional Foods & Beverages (2023-2034) ($MN)
  • Table 41 Global Personalized Nutrition and Genomics Market Outlook, By End User (2023-2034) ($MN)
  • Table 42 Global Personalized Nutrition and Genomics Market Outlook, By Fitness Enthusiasts (2023-2034) ($MN)
  • Table 43 Global Personalized Nutrition and Genomics Market Outlook, By Athletes & Sports Professionals (2023-2034) ($MN)
  • Table 44 Global Personalized Nutrition and Genomics Market Outlook, By General Consumers (2023-2034) ($MN)
  • Table 45 Global Personalized Nutrition and Genomics Market Outlook, By Geriatric Population (2023-2034) ($MN)
  • Table 46 Global Personalized Nutrition and Genomics Market Outlook, By Pediatric Population (2023-2034) ($MN)
  • Table 47 Global Personalized Nutrition and Genomics Market Outlook, By Patients with Chronic Diseases (2023-2034) ($MN)
  • Table 48 Global Personalized Nutrition and Genomics Market Outlook, By Healthcare & Wellness Providers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.